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Introduction
The current dialytic therapy has brought brilliant success
in prolonging patient survival in end-stage renal disease
(ESRD). In addition to the control of uremia, it can prevent
patients from extracellular volume (ECV) excess, dilutional
hyponatremia, severe hyperkalemia and metabolic acidosis.
However, it cannot keep patients in a steady state all the
time because of its incomplete therapeutic efficacy.
The concept of homeostasis is a cornerstone of phy-
siology. The concept of stability of the ‘milieu interieur
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(internal environment)’ was created by Claude Bernard in
the middle of the 19
th century, and it was developed to
the concept of homeostasis by Walter Cannon and popular-
ized in his book The Wisdom of the Body, published in
1932. Whereas normal kidneys contribute to maintaining
milieu interieur in a steady state, the current routine dia-
lytic treatment hardly offers ESRD patients homeostasis.
Thus, we can say that the current dialytic therapy is
“unphysiologic”.
One of the unphysiologic consequences in hemodialysis
patients is inadequate sodium balance. Sodium is accumu-
lated over the interdialytic period, and sodium removal by
dialysis may be insufficient because of the brief and dis-
continuous nature of routine dialytic therapy. Besides, su-
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praphysiologic dialysate sodium concentrations which are
frequently used in current practice may hamper normaliz-
ing sodium balance in hemodialysis patients.
Dialysis unphysiology
Carl Kjellstrand and his associates for the first time drew
attention to the issue of possible negative effects of the
unphysiology of intermittent dialysis treatment
1). They for-
mulated the “Unphysiology Hypothesis” which stated that
side effects seemed particularly common in patients who
experience great swings in body weight, urea (osmolality),
and potassium (K
+), and who had - as a consequence of
their large fluid load - severe hypertension. In other words,
the more "unphysiologic" dialysis is, and the more abnor-
mal blood chemistries and fluid levels are before dialysis,
the more violently they will change during dialysis and
the more ill-effects those patients will experience. The fast-
er and more violent the changes, the sicker the patients
become
2).
The best way which they contemplated to get rid of
"unphysiology" was to dialyze often - i.e., dialyze daily.
Keeping blood chemistries within normal limits may be
impossible with three dialyses per week. Before each dialy-
sis the patient would be fluid-overloaded, hyperkalemic,
and acidotic. When dialysis is over, the opposite phenom-
ena may occur. Thus the patient’s body is never in a normal
state; it is in an abnormal state, both before and after dialy-
sis
2).
Lopot and Válek proposed two parameters for quantifi-
cation of dialysis unphysiology: plasma urea time-averaged
concentration (TAC) and time average deviation (TAD)
3).
The latter represents mean deviation of plasma urea con-
centration from the TAC
4). The less frequent and thus less
physiological the dialysis schedule, the higher will be the
fluctuation of the plasma urea concentration and the higher
the resulting TAD. Treatment outcome of a specific treat-
ment schedule can be represented by a point on the
TAC/TAD plot. Fig. 1 shows the TAC/TAD plot represent-
ing currently used renal replacement therapies and health.
It was derived from an average patient with total body
water of 42 L, negligible residual renal function and a pro-
tein catabolic rate (PCR) of 1 g/kg/day dialyzed with a
urea clearance of 160 mL/min for the same total weekly
time (and thus, equal to weekly cleared volume)
3). It is
noted that peritoneal dialysis has less TAD than inter-
mittent hemodialysis.
Unphysiology of sodium balance in
hemodialysis patients
In hemodialysis patients without residual renal function,
intradialytic sodium removal should be matched with inter-
dialytic sodium accumulation. Sodium removal during he-
Fig. 1. The TAC/TAD plot from health and different treatment
modalities of renal replacement (Adapted from the previous
study
3)). TAC, time-averaged concentration; TAD, time average
deviation; HD, hemodialysis; APD, automated peritoneal dialy-
sis; NPD, nocturnal peritoneal dialysis; CAPD, continuous ambu-
latory peritoneal dialysis.
Fig. 2. Unphysiology of sodium balance in intermittent hemo-
dialysis (Adapted from the previous study
6)). The patient oscillates
between “wet” and “dry” state just before and just after the ses-
sion. The refilling of plasma volume from interstitial space takes
a few hours after the dialysis. UF, ultrafiltration.GH Kim : Dialysis Unphysiology and Sodium Balance 33
modialysis is carried out by convection and to a lesser de-
gree by diffusion. However, with supraphysiologic dialy-
sate sodium concentrations, diffusive influx from dialysate
may occur, especially in patients with low predialytic plas-
ma sodium concentrations
5).
Over the interdialytic period, the ECV is expanded fol-
lowing sodium intake. The ECV changes occurring in the
usual thrice weekly hemodialysis treatment are shown in
Fig. 2. Owing to the intermittent nature of hemodialysis,
the patient oscillates between a high-weight “wet” state
just before the session, and a low weight “dry” state just
at the end of the session
6). Thus, we can say that the inter-
mittent hemodialysis is “unphysiologic” in terms of sodium
balance as well. The discontinuous nature of hemodialysis
causes saw-tooth volume fluctuations, and the ECV ex-
pansion during the interdialytic period may lead to hyper-
tension and adverse cardiovascular consequences.
Fractions of sodium
Sodium ions (Na
+) may be divided into osmotically ac-
tive and osmotically inactive fractions
7). The traditional
view is that Na
+ and its accompanying anions are the prin-
cipal extracellular osmoles and act to hold water in the
extracellular space; conversely, K
+ salts account for almost
all the intracellular osmoles and act to hold water within
the cells. Although the cell membrane is permeable to both
Na
+ and K
+, these ions are able to act as effective osmoles
because they are restricted to their respective compartments
by the activity of the Na
+,K
+-ATPase pump in the cell
membrane
8). Thus, this fraction of Na
+ is osmotically active
because Na
+ accumulation inevitably leads to water re-
tention in the extracellular space (Fig. 3). In line with this
concept, as shown originally by short-term isotope dilution
studies done by Edelman et al.
9), changes in the serum
Na
+ concentration reflect short-term changes in the ex-
changeable fraction of total body Na
+ and K
+ relative to
total body water.
More recent data have suggested that large amounts of
Na
+ can be accumulated without accompanying water re-
tention
10, 11). Thus, plasma and extracellular water cannot
be the only sites of Na
+ and water metabolism, and tissues
such as bone, cartilage and connective tissue may account
for >50% of the total body Na
+ content. Some osmotically
inactive Na
+ in the crystalline phase of bone was postulated
in the 1960s
12). This localization may be interpreted as “an
internal Na
+ escape into extracellular matrix components”
to maintain the ECV despite a positive Na
+ balance
7). If
this Na
+ was bound in a “third” sodium space to negatively
charged interstitial matrix components with polyanionic
character or to the bone mineral, this bound Na
+ would
not readily equilibrate with the ECV (water-free Na
+ accu-
mulation) and thus would be osmotically inactive (Fig. 3).
Under conditions of total starvation, however, this osmoti-
cally inactive Na
+ can be mobilized and made available
Fig. 3. Fractions of sodium (Modified from the previous study
8)). The Na
+,K
+-ATPase pump in the cell
membrane actively transports sodium into the extracellular (EC) space, and Na
+ also passively moves into
the intracellular (IC) space. The former accompanies water movement and is osmotically active, and the
latter does not accompany water movement and is osmotically inactive.34 Electrolyte Blood Press 7:31-37, 2009
for exchange
13). Recently, osmotically inactive sodium
storage has been documented in humans
11) and rats con-
suming a high-salt diet
14).
The role of osmotically inactive Na
+ storage
in elevation of blood pressure
In patients with chronic renal failure, the blood pressure
(BP), when related to urinary sodium excretion, rises ex-
ponentially with the decrease of creatinine clearance
15).
Intravascular volume-to-extracellular volume ratio in-
creases more in patients with advanced renal insufficiency,
and BP increases more in relation to the increase of ECV
in these patients. The following Guyton’s 2 examples show
how, in the long run, small volume increases are associated
with high BP increases
16).
The first relates to changes in fluid volume and BP
caused by hyperaldosteronism in humans. In one study,
after hypertension was completely controlled by spi-
ronolactone, the drug was withheld for several weeks.
During the next 2 weeks, extracellular fluid volume and
BP increased by 20% to 40%. During the following 2
weeks, the ECV decreased toward normal, but BP re-
mained elevated. Yet no other cause for the elevated BP
was found in these patients, except for the small increase
in fluid volume. Another example was a study on circu-
latory system variables, after acute volume loading in dogs
with reduced kidney mass to 30%. The study showed, with-
in 2 days, an increased extracellular fluid and blood vol-
ume, increased cardiac output, slight decrease in total pe-
ripheral resistance, and a rise in BP. Within the following
few days, extracellular and blood volumes and cardiac out-
put decreased; however, total peripheral resistance in-
creased and BP remained elevated (Fig. 4)
17).
Guyton postulated that the BP remained elevated by in-
creased total peripheral resistance due to autoregulation of
blood flow at the tissue level
16). Recently, however, the
mechanisms leading to vasoconstriction in salt-dependent
hypertension are being understood more clearly. Either ex-
cessive sodium intake or sodium retention by the kidneys
and the consequent tendency toward plasma volume ex-
pansion lead to release of endogenous ouabain (EO) prob-
ably from the hypothalamus
18). The Na
+,K
+-ATPase pumps
in the vascular smooth muscle cells (VSMCs) are inhibited
by the increase in plasma EO, resulting in the elevation
of local Na
+ on the submembrane area. This produces elec-
trogenic depolarization of VSMCs and facilitates Ca
2+ en-
try through the Na
+/Ca
2+ exchanger. The resulting rise in
the cytosolic Ca
2+ concentration should promote vaso-
constriction and, in vivo, elevation of BP
19).
The lag phenomenon: delayed decreases in
BP after ECV normalization
Previous clinical observations revealed that the BP re-
sponse to ECV reduction was delayed by some weeks. This
represents the lag phenomenon, i.e., the delay of BP de-
Fig. 4. Changes in circulatory variables after volume loading in
dogs with reduced kidney mass to 30% (Modified from the
previous study
16)). Beginning at day 0, isotonic saline was infused
for 2 weeks at about 6 times normal sodium intake. Note that at
the fourteenth day extracellular fluid volume increased only 4%
compared to day 0, but blood pressure increased 40%, mostly due
to increased total peripheral resistance.GH Kim : Dialysis Unphysiology and Sodium Balance 35
crease after normalization of extracellular fluid volume
17).
It was first described in the middle of the twentieth century
after introduction of the “rice diet”
20, 21) and during treat-
ment with thiazide diuretics
22). In 1967, Scribner com-
mented that “in many patients a time lag exists between
reduction of ECV and adequate control of BP. Several days
or weeks may be required for adequate control, even
though striking weight loss and, presumably, reduction of
ECV occurred immediately.”
23)
The time-dependent relationship between the ECV con-
trol by hemodialysis and the normalization of BP can be
illustrated by the first year of dialysis of 712 patients start-
ed on hemodialysis in Tassin, France
24). During the first
month, ECV expressed by the postdialysis weight declined
sharply by 2 to 3 kg. Predialysis mean arterial pressure
also decreased rapidly. At 2 months, the postdialysis
weight was stable, but BP continued to decrease. At that
stage, antihypertensive medication was already stopped in
almost all patients. Between 3 and 12 months, the curves
crossed over, BP continued to decrease gently, but weight
increased by several kilograms (Fig. 5). This gain in weight
after 2 months was not related with an ECV increase but
with the anabolic gain in lean and fat body mass following
the start of dialysis
25).
There are several possible explanations for the lag
phenomenon. First, vascular remodeling
26), followed by a
progressive reduction of peripheral resistances, is con-
ceivable. Secondly, vasoactive middle molecular sub-
stances such as asymmetric dimethylarginine may be very
slowly removed
27). Thirdly, water-free sodium storage in
the VSMCs may be very slowly relieved because of the
restored Na
+,K
+-ATPase activity.
How to avoid sodium overload and
hypertension in hemodialysis patients
With current hemodialysis practice, unphysiology of so-
dium balance is inevitable. Specifically, the liberalization
of diet and short dialysis with a high sodium concentration
in the dialysate are the main causes of positive sodium
balance
28).
According to the national survey performed in 2005, the
average dietary sodium intake in Koreans was estimated
to be 5.2 grams per day. Educating patients to restrict so-
dium intake <2 grams per day, while maintaining a good
appetite, is not easy. Thus, reducing dietary sodium intake
remains the most important tool in improving BP control
in dialysis patients
5), and a low-salt diet is more than ever
a necessity in conventional hemodialysis
29).
Sodium removal can be increased both by applying
higher ultrafiltration volumes and by lowering dialysate so-
dium concentration
5). However, the former may be difficult
because of improper tolerance, and the latter may hamper
the hemodynamic stability during the dialysis. The ultra-
filtration rate is a major limiting factor because intra-
vascular compartment refilling from the interstitium needs
more time than is available with now-standard short ses-
sions
29). Thus, prolonging session length (long hemodial-
ysis) will be desirable to improve hemodialysis tolerance
while maintaining a high rate of ultrafiltration.
Current hemodialysis practices adopt a standard dialy-
sate sodium prescription that is typically higher than the
plasma sodium concentration of most patients. However,
hypertonic dialysate sodium prescriptions, including so-
dium modeling, predispose to positive sodium balance and
lead to higher BP and increased interdialytic weight gain
6).
Conversely, lowering or individualizing dialysate sodium
reduces thirst, interdialytic weight gain, and BP in non-hy-
Fig. 5. The lag phenomenon in first hemodialysis (HD) year from
the experience in Tassin: delayed decreases in predialysis mean
arterial pressure (MAP) after normalization of postdialysis weight
(Modified from the previous study
25)). Whereas almost 90% of
patients were on antihypertensive (AntiHT) medications at the start
of dialysis, <5% remained on antihypertensive drugs by the second
month of dialysis when a true dry body weight was achieved.36 Electrolyte Blood Press 7:31-37, 2009
potension prone dialysis patients
30). A random reduction
of 3 mEq/L in dialysate sodium was well tolerated even
by patients with preexisting hypotension
31), and the sodium
concentration in the dialysate may be reduced to <138
mEq/L
28). It has become possible to individualize dialysate
sodium concentration by means of online measurements
of plasma conductivity and adjustment of dialysate con-
ductivity by feedback technologies.
Conclusion
Sodium, which is accumulated over the interdialytic pe-
riod in ESRD patients, may be divided into two fractions.
The one is the fraction of osmotically active sodium which
is mainly confined to the extracellular space, and the other
is that of water-free (osmotically inactive) sodium which
diffuses into the intracellular space. Both contribute to the
pathogenesis of hypertension because the former may act
to expand extracellular fluid volume and the latter may
cause vasoconstriction in the long run by increasing cyto-
solic concentration of calcium in the vascular smooth mus-
cle cells (Fig. 6). Even in intensive hemodialysis, it may
take several weeks to months for water-free sodium storage
in the vascular smooth muscle cells to be relieved. This
may be an explanation for the lag phenomenon, i.e., the
delay of blood pressure decrease after normalization of ex-
tracellular fluid volume shown in the Tassin experience.
Modest restriction of dietary sodium intake, the dialytic
session length long enough to maintain a high ultra-
filtration volume, and the reasonably low dialysate sodium
concentration are required to avoid unphysiology of pos-
itive sodium balance in current hemodialysis practice.
References
1) Kjellstrand CM, Evans RL, Petersen RJ, Shideman JR, von
Hartitzsch B, Buselmeier TJ: The "unphysiology" of dialy-
sis: a major cause of dialysis side effects? Kidney Int
7(Suppl 2):30-34, 1975
2) Home dialysis central [Internet]. The Medical Education
Institute; c2004-2009 [cited 2009 Sep 21]. Available from:
http://www.homedialysis.org/
3) Lopot F, Valek A: Quantification of dialysis unphysiology.
Nephrol Dial Transplant 13(Suppl 6):74-78, 1998
4) Valek A, Lopot F: Uraemic toxins and blood purification
strategies. Contrib Nephrol 70:178-187, 1989
5) Kooman JP, van der Sande F, Leunissen K, Locatelli F:
Sodium balance in hemodialysis therapy. Semin Dial 16:
351-355, 2003
6) Charra B: Fluid balance, dry weight, and blood pressure
in dialysis. Hemodial Int 11:21-31, 2007
7) Titze J: Water-free sodium accumulation. Semin Dial 22:
253-255, 2009
8) Stiller S, Bonnie-Schorn E, Grassmann A, Uhlenbusch-
Körwer I, Mann H: A critical review of sodium profiling
for hemodialysis. Semin Dial 14:337-347, 2001
9) Edelman IS, Leibman J, O'Meara MP, Birkenfeld LW:
Interrelations between serum sodium concentration, serum
osmolarity and total exchangeable sodium, total exchange-
able potassium and total body water. J Clin Invest 37:1236-
1256, 1958
10) Heer M, Baisch F, Kropp J, Gerzer R, Drummer C: High
dietary sodium chloride consumption may not induce body
fluid retention in humans. Am J Physiol Renal Physiol 278:
F585-595, 2000
11) Titze J, Maillet A, Lang R, et al.: Long-term sodium balance
in humans in a terrestrial space station simulation study.
Am J Kidney Dis 40:508-516, 2002
12) Edelman IS, Leibman J: Anatomy of body water and
electrolytes. Am J Med 27:256-277, 1959
13) Garnett ES, Ford J, Golding PL, Mardell RJ, Whyman AE:
The mobilizaton of osmotically inactive sodium during total
starvation in man. Clin Sci 35:93-103, 1968
14) Titze J, Shakibaei M, Schafflhuber M, et al.: Glycosamino-
glycan polymerization may enable osmotically inactive Na+
storage in the skin. Am J Physiol Heart Circ Physiol 287:
H203-208, 2004
15) Koomans HA, Roos JC, Boer P, Geyskes GG, Mees EJ:
Salt sensitivity of blood pressure in chronic renal failure.
Evidence for renal control of body fluid distribution in man.
Fig. 6. Dialysis unphysiology of sodium balance contributing to
pathogenesis of hypertension. Osmotically active sodium acts to
expand extracellular volume (ECV), and water-free (osmotically
inactive) sodium causes vasoconstriction in the long run by in-
creasing cytosolic concentration of calcium in the vascular smooth
muscle cells. There is a time lag between corrections of ECV
expansion and vasoconstriction for the resolution of hypertension.GH Kim : Dialysis Unphysiology and Sodium Balance 37
Hypertension 4:190-197, 1982
16) Guyton AC: Kidneys and fluids in pressure regulation.
Small volume but large pressure changes. Hypertension 19
(Suppl 1):I2-8, 1992
17) Twardowski ZJ: Sodium, hypertension, and an explanation
of the "lag phenomenon" in hemodialysis patients. Hemodial
Int 12:412-425, 2008
18) Murrell JR, Randall JD, Rosoff J, et al.: Endogenous oua-
bain: upregulation of steroidogenic genes in hypertensive
hypothalamus but not adrenal. Circulation 112:1301-1308,
2005
19) Blaustein MP, Zhang J, Chen L, Hamilton BP: How does
salt retention raise blood pressure? Am J Physiol Regul
Integr Comp Physiol 290:R514-523, 2006
20) Kempner W: Treatment of hypertensive vascular disease
with rice diet. Am J Med 4:545-577, 1948
21) Murphy RJ: The effect of "rice diet" on plasma volume and
extracellular fluid space in hypertensive subjects. J Clin
Invest 29:912-917, 1950
22) Conway J, Lauwers P: Hemodynamic and hypotensive ef-
fects of long-term therapy with chlorothiazide. Circulation
21:21-27, 1960
23) Blumberg A, Nelp WB, Hegstrom RM, Scribner BH:
Extracellular volume in patients with chronic renal disease
treated for hypertension by sodium restriction. Lancet 2:69-
73, 1967
24) Charra B, Bergstrom J, Scribner BH: Blood pressure control
in dialysis patients: importance of the lag phenomenon. Am
J Kidney Dis 32:720-724, 1998
25) Charra B: Fluid balance, dry weight, and blood pressure
in dialysis. Hemodial Int 11:21-31, 2007
26) Gibbons GH, Dzau VJ: The emerging concept of vascular
remodeling. N Engl J Med 330:1431-1438, 1994
27) Khosla UM, Johnson RJ: Hypertension in the hemodialysis
patient and the "lag phenomenon": insights into pathophysi-
ology and clinical management. Am J Kidney Dis 43:739-
751, 2004
28) Perez-Garcia R, Lopez-Gomez JM, Jofre R, Junco E,
Valderrabano F: Haemodialysis dose, extracellular volume
control and arterial hypertension. Nephrol Dial Transplant
16(Suppl 1):98-101, 2001
29) Charra B, Chazot C: The neglect of sodium restriction in
dialysis patients: a short review. Hemodial Int 7:342-347,
2003
30) Santos SF, Peixoto AJ: Revisiting the dialysate sodium pre-
scription as a tool for better blood pressure and interdialytic
weight gain management in hemodialysis patients. Clin J
Am Soc Nephrol 3:522-530, 2008
31) Thein H, Haloob I, Marshall MR: Associations of a facility
level decrease in dialysate sodium concentration with blood
pressure and interdialytic weight gain. Nephrol Dial Trans-
plant 22:2630-2639, 2007